Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.76 USD | +10.00% | +12.10% | +211.50% |
05-09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
05-09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+211.50% | 323M | |
+30.38% | 684B | |
+29.22% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.85% | 240B | |
+9.18% | 208B | |
-7.85% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Oppenheimer Downgrades Nektar Therapeutics to Market Perform From Outperform, Adjusts Price Target to $6 From $21